BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15846253)

  • 1. Unexpected BNP levels in patients with advanced heart failure: a tale of caution and promise.
    Drazner MH; de Lemos JA
    Am Heart J; 2005 Feb; 149(2):187-9. PubMed ID: 15846253
    [No Abstract]   [Full Text] [Related]  

  • 2. B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure.
    O'Neill JO; Bott-Silverman CE; McRae AT; Troughton RW; Ng K; Starling RC; Young JB
    Am Heart J; 2005 Feb; 149(2):363-9. PubMed ID: 15846278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-type natriuretic peptide levels in obese patients with advanced heart failure.
    Horwich TB; Hamilton MA; Fonarow GC
    J Am Coll Cardiol; 2006 Jan; 47(1):85-90. PubMed ID: 16386669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low levels of B-type natriuretic peptide predict poor clinical outcomes in patients with chronic and advanced heart failure.
    Sun TW; Wang LX
    Med Hypotheses; 2007; 68(3):677-9. PubMed ID: 16899344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cut-off values of BNP and NT-BNP for diagnosis of heart failure in emergency service].
    Akpinar O; Kanadaşi M; Ilgenli TF
    Anadolu Kardiyol Derg; 2006 Dec; 6(4):395-6. PubMed ID: 17162299
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of BNP testing in heart failure.
    Doust J; Lehman R; Glasziou P
    Am Fam Physician; 2006 Dec; 74(11):1893-8. PubMed ID: 17168346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-type natriuretic peptide in heart failure.
    Moe GW
    Curr Opin Cardiol; 2006 May; 21(3):208-14. PubMed ID: 16601459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of b-type natriuretic peptide in heart failure management.
    Newton PJ; Betihavas V; Macdonald P
    Aust Crit Care; 2009 Aug; 22(3):117-23. PubMed ID: 19589695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-type natriuretic peptide (BNP) is more sensitive to rapid hemodynamic changes in acute heart failure than N-terminal proBNP.
    Mair J; Falkensammer G; Poelzl G; Hammerer-Lercher A; Griesmacher A; Pachinger O
    Clin Chim Acta; 2007 Apr; 379(1-2):163-6. PubMed ID: 17258185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of BNP testing.
    Hlatky M; Heidenreich P
    Arch Intern Med; 2006 May; 166(10):1063-4. PubMed ID: 16717166
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulating natriuretic peptide levels in acute heart failure.
    Maisel A
    Rev Cardiovasc Med; 2007; 8 Suppl 5():S13-21. PubMed ID: 18192949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the brain natriuretic peptide in heart failure management.
    Kalsmith BM
    Circ Heart Fail; 2009 Jul; 2(4):379. PubMed ID: 19808363
    [No Abstract]   [Full Text] [Related]  

  • 13. Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure.
    Omland T
    Crit Care Med; 2008 Jan; 36(1 Suppl):S17-27. PubMed ID: 18158473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-type natriuretic peptide and the stressed heart.
    Nohria A; Givertz MM
    J Am Coll Cardiol; 2006 Feb; 47(4):749-51. PubMed ID: 16487839
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pro: Natriuretic peptides as diagnostic tool. The analysis should be a routine in heart failure diagnosis].
    Dahlström U; Alehagen U
    Lakartidningen; 2006 Mar 22-28; 103(12):927-9. PubMed ID: 16618036
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experiences with serum BNP (B type natriuretic peptide) in patients with systolic and diastolic heart failure].
    Lukács I; Fey E; Kárpáti P
    Orv Hetil; 2005 Sep; 146(37):1919-23. PubMed ID: 16255376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure.
    Law YM; Ettedgui J; Beerman L; Maisel A; Tofovic S
    Am J Cardiol; 2006 Aug; 98(4):520-4. PubMed ID: 16893709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation.
    Campana C; Pasotti M; Klersy C; Alessandrino G; Albertini R; Magrini G; Ghio S; Tavazzi L
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):671-6. PubMed ID: 19444135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure.
    Iwanaga Y; Nishi I; Furuichi S; Noguchi T; Sase K; Kihara Y; Goto Y; Nonogi H
    J Am Coll Cardiol; 2006 Feb; 47(4):742-8. PubMed ID: 16487838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.